This discovery may lead to a novel treatment approach that targets underlying brain pressure mechanisms rather than just managing symptoms. The research suggests that liraglutide, a drug originally ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Over 12 weeks, 26 patients suffering frequent migraines and obesity received a daily dose of the GLP-1 agonist liraglutide. Remarkably, the average number of migraine days per month fell sharply ...

Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by ...

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as 47million Americans, a new study from researchers in Italy found.

Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests.. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking ...

Ozempic is approved in Canada as a treatment for type 2 diabetes, though it has garnered headlines for its off-label use as a weight-loss drug.

You may have heard about Ozempic — maybe you’ve even had its commercial jingle stuck in your head.. It’s a drug billed as revolutionary for the treatment of type 2 diabetes, but that’s not ...